Bringing the fundamentals into focus…
Back to Clinuvel Pharmaceuticals Limited
How Clinuvel Pharmaceuticals Limited stacks up
CUVL · against 311 other Healthcare companies of similar size
Overall
80/ 100
Near the top of its peers.
Ranked #6 of 312 · scores higher than 98% of peers
Bars: peers in each 10-point band of the overall score5 peers with an overall score of 80–89, including CUVL · Click a bar to see the companies
The four scores behind it
Overall = average of valuation, growth, profitability and safety percentile (categories without data are skipped)Ranking by overall score
Top 5 and the companies ranked around CUVL| Rank | Company | Market cap | Overall | Valuation | Growth | Profitability | Risk |
|---|---|---|---|---|---|---|---|
| 1 | 261M USD | 97 | 93 | — | 98 | 0 / 2 | |
| 2 | 2.9B HKD (≈$365M) | 84 | 99 | 63 | 86 | 0 / 2 | |
| 2 | 592M ILS (≈$160M) | 84 | 99 | 99 | 96 | 1 / 2 | |
| 4 | 433M USD | 81 | 96 | 99 | 99 | 2 / 2 | |
| 4 | 356M AUD (≈$235M) | 81 | 98 | 35 | 97 | 0 / 2 | |
| 6 | 256M USD | 80 | 98 | 35 | 92 | 0 / 2 | |
| 7 | 3.5B CNY (≈$491M) | 79 | 73 | 69 | 84 | 0 / 2 | |
| 8 | 2.7B CNY (≈$377M) | 77 | 88 | 61 | 90 | 0 / 2 | |
| 8 | 3.4B CNY (≈$478M) | 77 | 95 | 85 | 75 | 1 / 2 | |
| 8 | 353M EUR (≈$388M) | 77 | 84 | 60 | 94 | 0 / 2 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score